414 related articles for article (PubMed ID: 9191083)
21. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
Oviedo A; Glowa J; Herkenham M
Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
[TBL] [Abstract][Full Text] [Related]
22. Repeated administration with Delta9-tetrahydrocannabinol regulates mu-opioid receptor density in the rat brain.
Corchero J; Oliva JM; García-Lecumberri C; Martin S; Ambrosio E; Manzanares J
J Psychopharmacol; 2004 Mar; 18(1):54-8. PubMed ID: 15107185
[TBL] [Abstract][Full Text] [Related]
23. Perinatal delta9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats.
Corchero J; García-Gil L; Manzanares J; Fernández-Ruiz JJ; Fuentes JA; Ramos JA
Life Sci; 1998; 63(10):843-50. PubMed ID: 9734704
[TBL] [Abstract][Full Text] [Related]
24. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol.
Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA
Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852
[TBL] [Abstract][Full Text] [Related]
25. Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats.
Romero J; Berrendero F; Garcia-Gil L; de la Cruz P; Ramos JA; Fernández-Ruiz JJ
Neuroscience; 1998 Jun; 84(4):1075-83. PubMed ID: 9578396
[TBL] [Abstract][Full Text] [Related]
26. Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen.
Corchero J; Romero J; Berrendero F; Fernandez-Ruiz J; Ramos JA; Fuentes JA; Manzanares J
Brain Res Mol Brain Res; 1999 Apr; 67(1):148-57. PubMed ID: 10101241
[TBL] [Abstract][Full Text] [Related]
27. Delta9-tetrahydrocannabinol increases sequence-specific AP-1 DNA-binding activity and Fos-related antigens in the rat brain.
Porcella A; Gessa GL; Pani L
Eur J Neurosci; 1998 May; 10(5):1743-51. PubMed ID: 9751146
[TBL] [Abstract][Full Text] [Related]
28. Prenatal cannabinoid and gene expression for neural adhesion molecule L1 in the fetal rat brain.
Gómez M; Hernández M; Johansson B; de Miguel R; Ramos JA; Fernández-Ruiz J
Brain Res Dev Brain Res; 2003 Dec; 147(1-2):201-7. PubMed ID: 15068010
[TBL] [Abstract][Full Text] [Related]
29. Modulation of rat brain cannabinoid receptors after chronic morphine treatment.
Rubino T; Tizzoni L; Viganò D; Massi P; Parolaro D
Neuroreport; 1997 Oct; 8(15):3219-23. PubMed ID: 9351646
[TBL] [Abstract][Full Text] [Related]
30. Characterization and autoradiographic localization of the cannabinoid binding site in rat brain using [3H]11-OH-delta 9-THC-DMH.
Thomas BF; Wei X; Martin BR
J Pharmacol Exp Ther; 1992 Dec; 263(3):1383-90. PubMed ID: 1335065
[TBL] [Abstract][Full Text] [Related]
31. A detailed mapping of the histamine H(3) receptor and its gene transcripts in rat brain.
Pillot C; Heron A; Cochois V; Tardivel-Lacombe J; Ligneau X; Schwartz JC; Arrang JM
Neuroscience; 2002; 114(1):173-93. PubMed ID: 12207964
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain.
Glass M; Dragunow M; Faull RL
Neuroscience; 1997 Mar; 77(2):299-318. PubMed ID: 9472392
[TBL] [Abstract][Full Text] [Related]
33. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
[TBL] [Abstract][Full Text] [Related]
34. Age-related changes in CB1 receptor expression and function and the behavioral effects of cannabinoid receptor ligands.
Ginsburg BC; Hensler JG
Pharmacol Biochem Behav; 2022 Feb; 213():173339. PubMed ID: 35077729
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of hippocampal acetylcholine release after acute and repeated Delta9-tetrahydrocannabinol in rats.
Carta G; Nava F; Gessa GL
Brain Res; 1998 Oct; 809(1):1-4. PubMed ID: 9795096
[TBL] [Abstract][Full Text] [Related]
36. Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat.
Freedland CS; Whitlow CT; Miller MD; Porrino LJ
Synapse; 2002 Aug; 45(2):134-42. PubMed ID: 12112406
[TBL] [Abstract][Full Text] [Related]
37. Maternal exposure to delta9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central mu opioid receptors in adult offspring female rats.
Vela G; Martín S; García-Gil L; Crespo JA; Ruiz-Gayo M; Fernández-Ruiz JJ; García-Lecumberri C; Pélaprat D; Fuentes JA; Ramos JA; Ambrosio E
Brain Res; 1998 Oct; 807(1-2):101-9. PubMed ID: 9757010
[TBL] [Abstract][Full Text] [Related]
38. The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake.
Romero J; de Miguel R; Ramos JA; Fernández-Ruiz JJ
Life Sci; 1998; 62(4):351-63. PubMed ID: 9450507
[TBL] [Abstract][Full Text] [Related]
39. Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen.
Romero J; Berrendero F; Pérez-Rosado A; Manzanares J; Rojo A; Fernández-Ruiz JJ; de Yebenes JG; Ramos JA
Life Sci; 2000; 66(6):485-94. PubMed ID: 10794065
[TBL] [Abstract][Full Text] [Related]
40. Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain.
Melis M; Gessa GL; Diana M
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Aug; 24(6):993-1006. PubMed ID: 11041539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
